GELS
Gelteq Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$0.56
−3.07%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.62x
- Price / sales
- 53.35x
- Price / cash flow
- -1.60x
Enterprise value
- Enterprise value
- $9.9M
- EV / sales
- 84.17x
- EV / EBITDA
- -3.95x
- EV / EBIT
- -2.54x
- Market cap
- $6.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025